NEETPGAI
SubjectsBlogPricing
Log inStart Free
NEETPGAI

AI-powered NEET PG preparation platform. Master all 19 subjects with adaptive MCQs, AI tutoring, and spaced repetition.

Product

  • Subjects
  • Pricing
  • Blog

Features

  • Adaptive MCQ Practice
  • AI Tutor
  • Mock Tests
  • Spaced Repetition

Resources

  • Blog
  • Study Guides
  • NEET PG Updates
  • Help Center

Legal

  • Privacy Policy
  • Terms of Service

Stay updated

© 2026 NEETPGAI. All rights reserved.
Subjects/Surgery/Locally Advanced Esophageal Cancer Management
Locally Advanced Esophageal Cancer Management
hard
scissors Surgery

A 62-year-old man with a 40-year history of smoking presents with progressive dysphagia to solids for 3 months and unintentional weight loss of 8 kg. Endoscopy reveals a 5 cm ulcerated lesion in the mid-esophagus. Biopsy confirms squamous cell carcinoma. CT chest/abdomen shows no distant metastases, but there is invasion into the adjacent aorta. Which of the following is the most appropriate treatment strategy?

A. Neoadjuvant chemotherapy followed by esophagectomy
B. Definitive concurrent chemoradiation therapy alone
C. Palliative chemotherapy with best supportive care
D. Esophagectomy alone without neoadjuvant therapy

Explanation

## Locally Advanced Esophageal Cancer with Aortic Invasion **Key Point:** Aortic invasion is considered locally advanced disease (T4b) but NOT an absolute contraindication to curative intent therapy if there is no distant metastasis and the patient has adequate performance status. **Correct Answer: Definitive Concurrent Chemoradiation Therapy Alone** ### Rationale: - **Aortic invasion (T4b):** Makes the tumor unresectable by standard esophagectomy, as en bloc resection of the aorta carries prohibitive morbidity/mortality - **Current evidence (CROSS, RTOG 8501, NCCN guidelines):** Concurrent chemoradiation (CCR) is the standard of care for unresectable locally advanced esophageal cancer - **Survival outcomes:** CCR achieves 5-year survival of 20–30% in locally advanced disease, with acceptable toxicity - **Why not surgery:** Aortic invasion makes R0 resection impossible without major vascular reconstruction, which is not standard in esophageal cancer - **Performance status:** Patient is suitable for CCR (no mention of poor PS) ### High-Yield: T4b (aortic invasion) → CCR is curative intent. Neoadjuvant chemo + surgery is for resectable T4a (pleura/pericardium). ### Clinical Pearl: If patient had T4a (pleura/pericardium invasion) without aortic involvement, neoadjuvant chemotherapy + esophagectomy would be appropriate.

Practice similar questions

Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.

Start Practicing Free More Surgery Questions